CellSeed Inc.
Tokyo Stock ExchangeTotal Valuation
CellSeed Inc. carries a market capitalization of 8.82B, placing it among publicly traded companies globally. Its enterprise value stands at 9.21B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.82B |
| Enterprise Value | 9.21B |
Share Statistics
CellSeed Inc. currently has 33.45M shares outstanding.
| Shares Outstanding | 33.45M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 56.32, and the price-to-book ratio stands at 21.71.
| PE Ratio | N/A |
| PS Ratio | 56.32 |
| PB Ratio | 21.71 |
| P/TBV Ratio | 5.31 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 46.16 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 5,175.92 |
Financial Position
CellSeed Inc. maintains a current ratio of 16.78, meaning it holds 16.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.97, indicating elevated leverage, while an interest coverage ratio of -451.99 demonstrates limited ability to service its debt obligations.
| Current Ratio | 16.78 |
| Quick Ratio | 15.82 |
| Debt / Equity | 6.97 |
| Debt / EBITDA | -0.18 |
| Interest Coverage | -451.99 |
Financial Efficiency
| Return on Equity (ROE) | -148.49 |
| Return on Assets (ROA) | -42.79 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.65 |
Taxes
| Income Tax | 1.62M |
| Effective Tax Rate | N/A |
Stock Price Statistics
CellSeed Inc.'s stock has declined approximately -56.42994% over the past 52 weeks. The 50-day moving average sits at 274.90, while the 200-day moving average is 342.71.
| Beta (5Y) | N/A |
| 52-Week Price Change | -56.42994% |
| 50-Day Moving Average | 274.90 |
| 200-Day Moving Average | 342.71 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, CellSeed Inc. generated 199.47M in revenue and converted that into -957.03M in net income, yielding earnings per share of -30.16. EBITDA reached -802.73M, while operating income came in at -802.73M.
| Revenue | 199.47M |
| Gross Profit | 110.46M |
| Operating Income | -802.73M |
| Pretax Income | -955.41M |
| Net Income | -957.03M |
| EBITDA | -802.73M |
| EBIT | -802.73M |
| Earnings Per Share (EPS) | -30.16 |
Balance Sheet
CellSeed Inc. holds 2.17B in cash and equivalents against 147.50M in total debt, resulting in a net debt position of -2.03B. Total book value stands at 517.61M, with working capital of 2.17B providing operational flexibility.
| Cash & Cash Equivalents | 2.17B |
| Total Debt | 147.50M |
| Net Debt | -2.03B |
| Equity (Book Value) | 517.61M |
| Book Value Per Share | 16.31 |
| Working Capital | 2.17B |
Margins
CellSeed Inc. operates with a gross margin of 55.38, reflecting its pricing power and cost economics. The operating margin of -402.43 and net profit margin of -479.79 provide insight into operational efficiency.
| Gross Margin | 55.38 |
| Operating Margin | -402.43 |
| Pretax Margin | -478.97 |
| Profit Margin | -479.79 |
| EBITDA Margin | -402.43 |
Scores
CellSeed Inc. posts an Altman Z-Score of 20.57, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 20.57 |